logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dominik Paul Modest

german cancer research center (dkfz)
H指数:44
被引数:9,213

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

改变的身体成分与接受和不接受心脏毒性治疗癌症患者中心脏消耗的关联

British Journal of Pharmacology
IF7.7
2026-10-070
OAAI
Sara Hadzibegovic; Jonathan L. Hella; Jan Porthun; Alessia Lena; Danara Krug; Iulia Baluta; Ursula Wilkenshoff; Amir A. Mahabadi; Matthias Totzeck; Tienush Rassaf; Stefan D. Anker; Wolfram Doehner; Ulrich Keller; Lars Bullinger; Dominik P. Modest; Barry J. A. Laird; Richard J. E. Skipworth; John G. F. Cleland; Christian Oeing; Stephan von Haehling; Ulf Landmesser; Markus S. Anker
Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial

索托拉西布联合帕尼单抗和5-氟尿嘧啶在不可切除的KRAS G12C突变结直肠癌患者一线治疗中的应用（不适用双药/三药化疗）：ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO试验

Digestive and Liver Disease
IF3.8
2026-05-010
OAAI
Adrien Grancher; Matteo Landi; Alexej Ballhausen; Rosario Vidal Tocino; Annabel Alig; Ada Taravella; Karine Le Malicot; Emilie Soularue; Claire Gallois; Meriem Guarssifi; Manon Pelkowski; Marta Beltran; Lisa Kochen; Laura Delliponti; Julien Taïeb; Javier Sastre; Dominik Paul Modest; Chiara Cremolini; Thibault Mazard; David Tougeron
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer

Sotorasib联合帕尼单抗与曲氟尿苷/替匹嘧啶联合贝伐单抗在化疗耐药性转移性结直肠癌中的匹配调整间接比较

Clinical Colorectal Cancer
IF3.2
2026-04-230
PRE
Lisa Salvatore; Marwan Fakih; Yasutoshi Kuboki; David S. Hong; Dominik Paul Modest; Julien Taieb; Timothy Jay Price; Chiara Cremolini; Istvan Matyas Majer; Marko Rehn; Emily Chan; Ziyan Chen; Qui Tran; Filippo Pietrantonio
Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC

基于液体活检检测获得性MET耐药性使MET融合阳性NSCLC患者能够进行序贯靶向治疗

The Oncologist
IF0
2026-04-210
OA
Stanislav Rosnev; Katharina Klein; Lukas Heukamp; Julian Lenk; Maria Joosten; Markus Möbs; Tobias Grob; Manuela Benary; Loredana Vecchione; Claus-Eric Ott; Dominik P Modest; Maren Knödler; Ulrich Keller; Nikolaj Frost; Ulrich Keilholz; Philipp Kiewe; Damian T Rieke; null
Impact of Sex on Efficacy and Safety of 1st-Line Treatment with FOLFIRI plus Cetuximab or Bevacizumab in RAS/BRAF Wildtype Metastatic Colorectal Cancer– A subgroup analysis of the FIRE-3 (AIO KRK-0306) Trial

性別对FOLFIRI联合西妥昔单抗或贝伐珠单抗作为RAS/BRAF野生型转移性结直肠癌一线治疗方案有效性和安全性的影响——FIRE-3 (AIO KRK-0306)试验的亚组分析

European Journal of Cancer
IF7.1
2025-11-220
PRE
Kathrin Heinrich; Sebastian Stintzing; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Florian Kaiser; Salah-Eddin Al-Batran; Tobias Heintges; Christoph Lerchenmüller; Christoph Kahl; Gernot Seipelt; Frank Kullmann; Markus Moehler; Werner Scheithauer; Andreas Jung; Julian W. Holch; Swantje Held; Dominik Paul Modest; Volker Heinemann
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: a pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

抗EGFR抗体与抗VEGF抗体在BRAFV600E突变型转移性结直肠癌中根据原发肿瘤侧性的初始治疗疗效：一项在mCRC初始治疗中进行的七项临床试验的合并分析（德国AIO研究组）

European Journal of Cancer
IF7.1
2025-11-130
OAAI
Lena Weiss; Sebastian Stintzing; Dominik Paul Modest; Arndt Stahler; Ludwig Fischer von Weikersthal; Anke Reinacher-Schick; Thomas Decker; Victoria Probst; Kathrin Heinrich; Ingo Schwaner; Florian Kaiser; Rudolf Pihusch; Martin Fuchs; Swantje Held; Annabel Alig; Birgit Gruenberger; Gerald Werner Prager; David Tougeron; Julien Taieb; Volker Heinemann
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer Patients

虚弱及其在晚期癌症患者中的预后作用与简单FRAIL和Fried虚弱问卷的识别

Journal of Cachexia, Sarcopenia and Muscle
IF0
2025-10-120
OAAI
Pia Weinländer; Sara Hadzibegovic; Jan Porthun; Lucie Kretzler; Ruben Evertz; Alessia Lena; Laura-Carina Lück; Jonathan L. Hella; Ursula Wilkenshoff; Andrea Stroux; Kalliopi Keramida; Anne Letsch; Dominik Paul Modest; Lars Bullinger; Ulrich Keller; Mahir Karakas; Youssef S. Abdelwahed; Philipp Attanasio; Ursula Rauch; Carsten Skurk; Wolfram Doehner; Ulf Landmesser; Stephan von Haehling; Markus S. Anker
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)

请提供需要翻译的英文句子。

European Heart Journal
IF35.6
2025-08-300
OAAI
Markus S Anker; Amir A Mahabadi; Matthias Totzeck; Mitra Tewes; Muhammad Shahzeb Khan; Raluca I Mincu; Ulrike B Hendgen-Cotta; Lars Michel; Baicy Mathew; Ophelia Drescher; Martin Schuler; Ulrich Keller; Kathrin Rieger; Johann Ahn; Lars Bullinger; Dominik P Modest; Corinna Denecke; Lucie Kretzler; Luisa V Ramer; Danara Krug; Ulf Landmesser; Lorenz H Lehmann; Norbert Frey; Sven Bercker; Ulrich Laufs; Michael Böhm; Felix Mahfoud; Bela Merkely; Monika Diek; Javed Butler; Anja Veiser; Tim Heise; Martin Hellmich; Marius Placzek; Tim Friede; Stefan D Anker; Tienush Rassaf; null
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials

原发肿瘤侧别及负超选择对RAS野生型转移性结直肠癌患者抗EGFR为基础维持疗法的影响：两项随机临床试验的个体患者数据合并分析

British Journal of Cancer
IF6.8
2025-08-280
OAAI
Alexej Ballhausen; Federica Morano; Arndt Stahler; Sara Lonardi; Andreas Jay Kind; Chiara Cremolini; Susanna Swoboda; Giovanni Randon; David Horst; Michele Prisciandaro; Annabel Helga Sophie Alig; Chiara Carlotta Pircher; Armin Jarosch; Paola Andena; Annika Kurreck; Anna Alessandra Chiaramonte; Sebastian Stintzing; Filippo Pietrantonio; Dominik Paul Modest; Alessandra Raimondi
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial

对有心脏消耗风险、患有晚期癌症的心力衰竭患者进行随机化治疗的调查：EMPATICC试验的背景与设计

European Journal of Heart Failure
IF10.8
2025-08-260
OAAI
Markus S. Anker; Amir A. Mahabadi; Matthias Totzeck; Mitra Tewes; Raluca Mincu; Muhammad Shahzeb Khan; Javed Butler; Ulrich Keller; Johann Ahn; Lars Bullinger; Dominik P. Modest; Ulf Landmesser; Lorenz H. Lehmann; Sven Bercker; Ulrich Laufs; Michael Böhm; Bela Merkely; Monika Diek; Tim Heise; Martin Hellmich; Marius Placzek; Tim Friede; Stefan D. Anker; Tienush Rassaf
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO

转移性结直肠癌一线治疗中疾病进展的风险，以指导疾病再评估——AIO和GONO对11项试验的分析

Annals of Oncology
IF65.4
2025-08-190
OAAI
M.M. Germani; V. Heinemann; D. Rossini; L. Fischer von Weikersthal; F. Pietrantonio; K. Heinrich; A. Stahler; S. Lonardi; F. Kaiser; T. Decker; L. Salvatore; L. Weiss; F. Morano; M. Fuchs; F. Bergamo; C. Antoniotti; G. Masi; S. Stintzing; P. Frumento; C. Cremolini; D.P. Modest
Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

KRASG12C突变化疗难治性转移性结直肠癌患者接受Sotorasib联合帕尼单抗或标准治疗（CodeBreaK 300）：一项III期随机临床试验的结果

lancet oncology
IF0
2025-08-110
OAAI
Dominik Paul Modest; Marwan Fakih; Lisa Salvatore; Taito Esaki; David Páez Lopez-Bravo; Julien Taieb; Michalis Karamouzis; Erika Ruiz-Garcia; Tae Won Kim; Yasutoshi Kuboki; Fausto Meriggi; David Cunningham; Kun-Huei Yeh; Chiara Cremolini; Qui Tran; Emily Chan; Joseph Chao; Istvan Matyas Majer; Filippo Pietrantonio
Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer

晚期癌症患者中心脏消耗的临床和超声心动图表型

European Journal of Heart Failure
IF10.8
2025-08-060
OAAI
Markus S. Anker; Muhammad Shahzeb Khan; Anja Nikolski; Jan Porthun; Muhammad Sameer Arshad; Sara Hadzibegovic; Alessia Lena; Lucie Kretzler; Jonathan L. Hella; Marco Witkowski; Kathrin Rieger; Johann Ahn; Dominik P. Modest; Ulrich Keller; Lars Bullinger; Matthias Totzeck; Amir A. Mahabadi; Tienush Rassaf; Nikolaus Buchmann; Philipp Attanasio; Tanja Zeller; Mahir Karakas; Carlo G. Tocchetti; Ursula Wilkenshoff; John G. F. Cleland; Stephan von Haehling; Javed Butler; Ulf Landmesser
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA phase II randomized trial

FOLFIRINOX或FOLFOX用于局部晚期或转移性小肠腺癌：PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA II期随机试验

Digestive and Liver Disease
IF3.8
2025-07-280
OAAI
Thomas Aparicio; Anthony Turpin; Aziz Zaanan; Christelle de la Fouchardière; Karine Le Malicot; Sara Lonardi; Dominik Paul Modest; Richard Wilson; Chiara Cremolini; Alexej Ballhausen; Janet Graham; Annika Kurreck; Meriem Guarssifi; Magali Svrcek; Pierre Laurent-Puig; Sylvain Manfredi
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial

曲氟尿苷替匹嘧啶联合贝伐珠单抗对难治性转移性结直肠癌肿瘤缩小和应答深度的影响：SUNLIGHT试验分析

European Journal of Cancer
IF7.1
2025-07-120
OA
Julien Taieb; Dominik P. Modest; Marwan Fakih; Fortunato Ciardiello; Eric Van Cutsem; Elena Elez; Cristina Gravalos; Arinilda Campos Bragagnoli; Valentine Barboux; Lucas Roby; Nadia Amellal; Gerald W. Prager

研究方向

暂未获取到该数据
S
Sebastian Stintzing
H 指数:49论文数:799被引数:1.1万
L
Ludwig Fischer von Weikersthal
H 指数:41论文数:292被引数:9,550
V
Volker Heinemann
H 指数:91论文数:1,250被引数:4.3万
A
Arndt Stahler
H 指数:16论文数:162被引数:988
S
Swantje Held
H 指数:24论文数:181被引数:2,767
T
Thomas Decker
H 指数:61论文数:573被引数:1.6万
A
Andreas Jung
H 指数:70论文数:399被引数:2.1万
K
Kathrin Heinrich
H 指数:20论文数:161被引数:2,689
A
Annika Kurreck
H 指数:9论文数:94被引数:416
T
Thomas Kirchner
H 指数:75论文数:545被引数:2.2万